tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
JANX
Janux Therapeutics Inc
RESEARCH TOOLSreports

Janux Therapeutics Inc (JANX) Stock News & Sentiment

714 Followers
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
Premium
Ratings
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
1M ago
JANX
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Premium
Ratings
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
1M ago
JANX
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
Premium
Ratings
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
1M ago
JANX
Janux Therapeutics Inks Global Oncology Collaboration With BMS
Premium
Company Announcements
Janux Therapeutics Inks Global Oncology Collaboration With BMS
3M ago
8K
JANX
Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile
Premium
Ratings
Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile
3M ago
JANX
3 ‘Strong Buy’ Stocks to Buy Today,12/29/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/29/2025, According to Top Analysts
3M ago
SOC
JANX
Maintaining Buy on Janux: Trial Progress and Undervalued Pipeline Create Compelling Risk–Reward
Premium
Ratings
Maintaining Buy on Janux: Trial Progress and Undervalued Pipeline Create Compelling Risk–Reward
3M ago
JANX
More JANX News >

JANX News on the Web

JonesTrading Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
TipRanks News
Bullish
Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
Zacks
Bullish
Janux announces development candidate nomination under Bristol Myers collab
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Veeva Systems (VEEV) and Janux Therapeutics Inc (JANX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Janux Therapeutics Inc (JANX)
TipRanks News
Neutral
Janux Therapeutics price target lowered to $80 from $100 at Truist
TipRanks News
Neutral
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
TipRanks News
Bullish
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
JANX
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JANX’s Media Buzz Sentiment?
3 articles about JANX were published this week. In an average week, 1 articles are published.
    What is JANX’s weekly average amount of articles?
    In an average week, 1 articles about JANX are published.
      What is JANX’s News Sentiment?
      100% of articles about JANX were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        ADAGAdagene
        NBIXNeurocrine
        ANGOAngioDynamics
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week